Mid Atlantic Bio Angels

About The Fund

Mid Atlantic Bio Angels (MABA) is an angel investor group focused exclusively on new and emerging life science companies. Their investment thesis revolves around identifying and nurturing innovative startups within the healthcare and wellness, life science, and other related industries. MABA operates based on a belief in the transformative potential of life science technologies and the positive impact they can have on society. The group's investment process involves a rigorous assessment of potential investments with an emphasis on scientific innovation, market potential, and the capability of the management team. MABA engages in investments ranging from a minimum of $1,500,000 to a maximum of $5,230,000, targeting startups that demonstrate potential for high growth and merging opportunities. The group, which is based in New York, New York, offers not only financial capital but also mentorship and access to a network of industry professionals to support the development and scaling of portfolio companies. They provide funding to entrepreneurs through various stages of a company's growth, ensuring that startups have the necessary resources to progress from early development to market readiness. Additionally, MABA holds events such as '1st Pitch' to bring together investors and entrepreneurs for pitching opportunities and to facilitate feedback, and they have established Sidecar Funds to co-invest alongside angel investors in promising ventures. Their blog provides insights and information relevant to the life science investment community. Overall, MABA's activities reflect a commitment to fostering innovation and advancing the life sciences sector through strategic investments and dedicated support for entrepreneurial ventures.